The development of early warning systems for infectious diseases has the potential to bring major human and economic benefits.
Patients will benefit by gaining faster access to treatment and follow-up care, thus potentially speeding recovery and reducing the risk of suffering and death.
Populations will benefit from the reduced spread of infection and antibiotic resistance.
The NHS and global healthcare providers will benefit from more cost-effective care, improved stewardship of antimicrobials and informed intervention programmes.
Public health systems will benefit from more timely, targeted efforts to prevent disease spread and protect populations.